GLP-1 Receptor Agonists for Treatment of Pediatric Obesity: Behavioral Health Considerations

Childhood Obesity · Published 2025-04-30 · DOI 10.1089/chi.2024.0418

Authors being retrieved — see the publisher record. https://doi.org/10.1089/chi.2024.0418

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Protecting Musculoskeletal Development and Physical Function in Adolescents on GLP-1 Therapy · Childhood Obesity · 2026 · Cites or is cited by this article · Same journal
• Caring for Kids of All Sizes: An Outpatient Quality Improvement Pilot Project to Decrease Weight Stigma · Childhood Obesity · 2025 · Same journal
• Differential Participation: Comparison of Latino and Non-Latino Families in Fitline, a Family-Centered Weight Management Intervention · Childhood Obesity · 2026 · Same journal
• Psychosocial Outcomes Reported in Randomized Behavioral Intervention Trials for Children and Adolescents with Overweight and Obesity: A Scoping Review · Childhood Obesity · 2026 · Same journal
• Parental and Provider Perceptions of Social Care Impacts on Infant Nutrition · Childhood Obesity · 2026 · Same journal
• Maternal Mediterranean Diet during Pregnancy and Adiposity from Early Childhood through Preadolescence · Childhood Obesity · 2026 · Same journal
• Adherence to Health Behavior Recommendations among Youth with Obesity Classes I, II, and III · Childhood Obesity · 2026 · Same journal
• Group-Based Fat Mass Index Trajectories in Boys and Girls from Elementary to High School · Childhood Obesity · 2025 · Same journal
• Recruiting Adolescent Metabolic and Bariatric Surgery Patients for Research Studies: Assessing a Community-Partnered Approach · Childhood Obesity · 2026 · Same journal
• Weight Loss Effect of Lisdexamfetamine in Children with Severe Obesity: A Case Series · Childhood Obesity · 2025 · Same journal